ACHE and Alzheimer disease: One hypothesis is that there is interaction with the cholinergic system since the treatment with idalopirdine (Figure 13), a 5-HT6 receptor antagonist, gave a synergistic effect in improving cognition with an AChE inhibitor in both animal models and AD patients [67].